Metabolic dysfunction-associated steatohepatitis (MASH)1 previously known as Non-alcoholic steatohepatitis (NASH) is a serious liver condition that has been gaining attention due to its increasing prevalence2,3 and the limited number of FDA-approved treatments. The global prevalence of Metabolic dysfunction- associated fatty liver…